Journal of Clinical Microbiology

Latest Advances in Laboratory Detection of Mycoplasma genitalium..  e0079021. 2023

Answer to Photo Quiz: a Woman with a Pruritic Rash and Unilateral Vision Loss.  60. 2022

Photo Quiz: a Woman with a Pruritic Rash and Unilateral Vision Loss.  60. 2022

Multicenter Comparison of Nucleic Acid Amplification Tests for the Diagnosis of Rectal and Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Infections.  60. 2022

Trichomonas vaginalis detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG test.  59. 2021

Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).  59:e0178420. 2021

Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure.  59:e0054021. 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus.  59. 2021

Molecular characterization of Mycoplasma pneumoniae isolates in the United States from 2012 to 2018.  58. 2020

Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected Sepsis.  58. 2020

Characteristics of mycoplasma genitalium urogenital infections in a diverse patient sample from the United States: Results from the aptima mycoplasma genitalium evaluation study (AMES).  58. 2020

Evaluation of commercial molecular diagnostic methods for detection and determination of macrolide resistance in mycoplasma pneumoniae.  58. 2020

Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG test.  58. 2020

Clinical validation of the aptima bacterial vaginosis and aptima Candida/Trichomonas vaginitis assays: Results from a prospective multicenter clinical study.  58. 2020

Performance of the ALethia CMV assay for detection of cytomegalovirus by use of neonatal saliva swabs.  58. 2020

Prospective evaluation of molecular assays for diagnosis of vaginitis.  58. 2020

Development for Clinical Use of a Multiplexed Immunoassay Using Sputum Samples for Streptococcus pneumoniae: A non-culture-based approach for serotype-specific detection.  57. 2019

Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniae.  57. 2019

Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a national surveillance program.  57. 2019

Molecular testing for mycoplasma genitalium in the United States: Results from the AMES prospective multicenter clinical study.  57. 2019

The tail wagging the dog (or the challenges faced when the financing of medicine gets ahead of the science of medicine).  56. 2018

Performance of chlamydia trachomatis OmcB enzyme-linked immunosorbent assay in serodiagnosis of chlamydia trachomatis infection in women.  56. 2018

Control of artifactual variation in reported intersample relatedness during clinical use of a mycobacterium tuberculosis sequencing pipeline.  56. 2018

Diagnostic performance of a molecular test versus clinician assessment of vaginitis.  56. 2018

Quantitative thresholds enable accurate identification of clostridium difficile infection by the luminex xTAG gastrointestinal pathogen panel.  56. 2018

Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: The serial therapeutic and antifungal monitoring protocol (STAMP) trial.  56. 2018

Evaluation of the performance of the cobas CT/NG test for use on the cobas 6800/8800 systems for detection of chlamydia trachomatis and neisseria gonorrhoeae in male and female urogenital samples.  57. 2018

Clinical evaluation of the cepheid xpert tv assay for detection of trichomonas vaginalis with prospectively collected specimens from men and women.  56. 2018

Thinking beyond the common Candida species: Need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris.  55:3324-3327. 2017

Citrate anticoagulant improves the sensitivity of borreliella (borrelia) burgdorferi plasma culture.  55:3297-3299. 2017

WciG O-acetyltransferase functionality differentiates pneumococcal serotypes 35C and 42.  55:2775-2784. 2017

Meatal swabs contain less cellular material and are associated with a decrease in gram stain smear quality compared to urethral swabs in men.  55:2249-2254. 2017

Discovery of novel pneumococcal serotype 35D, a natural WciG-deficient variant of serotype 35B.  55:1416-1425. 2017

Stability studies on dry swabs and wet mailed swabs for detection of chlamydia trachomatis and neisseria gonorrhoeae in aptima assays.  55:971-977. 2017

Clinical and microbiological aspects of β-lactam resistance in staphylococcus lugdunensis.  55:585-595. 2017

A pyrosequencing-based approach to high-throughput identification of influenza A(H3N2) virus clades harboring antigenic drift variants.  55:145-154. 2017

Combined testing for chlamydia, gonorrhea, and trichomonas by use of the BD max CT/GC/TV assay with genitourinary specimen types.  55:155-164. 2017

Clinical significance of commensal gram-positive rods routinely isolated from patient samples.  54:2928-2936. 2016

Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes.  54:2470-2484. 2016

Closing the brief case: Recurrent granulomatous mastitis due to corynebacterium kroppenstedtii.  54:2212. 2016

Recurrent granulomatous mastitis due to corynebacterium kroppenstedtii.  54:1938-1941. 2016

Pneumococcus with the "6E" CPS locus produces serotype 6B capsular polysaccharide.  54:967-971. 2016

Clinical and laboratory testing for trichomonas vaginalis infection.  54:7-12. 2016

Comparison of molecular characteristics of mycoplasma pneumonia specimens collected from the United States and China.  53:3891-3893. 2015

Investigating the epidemiology of repeat chlamydia trachomatis detection after treatment by Using C. trachomatis OmpA genotyping.  53:546-549. 2015

Reply to "tn4401 Carrying blaKPC is inserted within another insertion in pKpQIL and related plasmids".  52:4450. 2014

Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system.  52:885-889. 2014

A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.  52:2804-2812. 2014

Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR (Journal of Clinical Microbiology (2009) 47, 3, (721-726)).  52:3137. 2014

Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.  52:1060-1063. 2014

ESwab as an optional collection device for use with the Affirm VPIII microbial test system.  52:1698-1700. 2014

Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis c outbreak investigation.  52:2650-2652. 2014

Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation.  52:758-765. 2014

Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women.  51:3694-3699. 2013

Diagnostic rates differ on the basis of the number of read days with the use of the Inpouch culture system for Trichomonas Vaginalis screening.  51:3875-3876. 2013

Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060)).  51:2806. 2013

Performance of the cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  51:1666-1672. 2013

Comparison of the abbott m2000 realtime CT assay and the cepheid genexpert CT/NG assay to the roche amplicor CT assay for detection of chlamydia trachomatis in ocular samples from Tanzania.  51:1611-1613. 2013

Michael A. Pfaller, M.D..  51:390-392. 2013

Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.  50:3542-3547. 2012

Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test.  50:3466-3471. 2012

Genetic characterization of Trichomonas vaginalis isolates by use of multilocus sequence typing.  50:3293-3300. 2012

From quellung to multiplex PCR, and back when needed, in pneumococcal serotyping.  50:2727-2731. 2012

Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis.  50:2321-2329. 2012

Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  50:2244-2249. 2012

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.  50:2040-2046. 2012

Comparative performance of human papillomavirus DNA testing using novel sample collection methods.  49:4185-4189. 2011

Molecular testing for Trichomonas vaginalis in women: Results from a prospective U.S. clinical trial.  49:4106-4111. 2011

Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.  49:3325-3328. 2011

Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms.  49:3033-3035. 2011

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.  49:2818-2826. 2011

Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006.  49:2404-2410. 2011

Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.  49:2210-2215. 2011

Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008.  49:1943-1950. 2011

Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation.  49:1646-1649. 2011

Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.  49:534-538. 2011

Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations.  48:4649-4651. 2010

Caught in the act: In vivo development of macrolide resistance to Campylobacter jejuni infection.  48:3012-3015. 2010

Cross-reactivity of current serogroup 6 factor sera from Statens Serum Institut with the recently described pneumococcal serotype 6D.  48:3044-3045. 2010

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.  48:2715-2723. 2010

Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: Comparison of five tissue DNA extraction methods using panfungal PCR.  48:2147-2153. 2010

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.  48:1827-1832. 2010

Repetitive extragenic palindromic PCR for study of Streptococcus mutans diversity and transmission in human populations.  48:599-602. 2010

Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network.  47:3138-3141. 2009

Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network.  47:3271-3275. 2009

Influenza A virus subtyping: Paradigm shift in influenza diagnosis.  47:3055-3056. 2009

Diversity of group B streptococcus serotypes causing urinary tract infection in adults.  47:2055-2060. 2009

Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations.  47:2353-2354. 2009

"Dodgy 6As": Differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction.  47:1981-1982. 2009

Ureaplasma parvum as a cause of sternal wound infection.  47:1976-1978. 2009

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections..  47:902-907. 2009

Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.  47:721-726. 2009

PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.  47:554-559. 2009

Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium.  46:3134-3135. 2008

Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. academic centers from 1995 to 1999.  46:1285-1291. 2008

Cytomegalovirus strain diversity in seropositive women.  46:882-886. 2008

Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.  45:3270-3276. 2007

USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections.  45:3431-3433. 2007

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in north American women by testing SurePath liquid-based pap specimens in APTIMA assays.  45:2434-2438. 2007

Nonsporulating clinical isolate identified as Petromyces alliaceus (Anamorph Aspergillus alliaceus) by morphological and sequence-based methods.  45:2701-2703. 2007

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.  45:1936-1940. 2007

Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.  45:1648-1651. 2007

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.  45:1225-1233. 2007

Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  45:747-751. 2007

GeneChip resequencing of the smallpox virus genome can identify novel strains: A biodefense application.  45:358-363. 2007

Methods for detection of Trichomonas vaginalis in the male partners of infected women: Implications for control of trichomoniasis.  44:3994-3999. 2006

Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India.  44:3055-3064. 2006

Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.  44:3368-3370. 2006

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates.  44:2481-2484. 2006

Phaeoacremonium parasiticum infections confirmed by β-tubulin sequence analysis of case isolates.  44:2207-2211. 2006

Fluoroquinolone resistance in Ureaplasma parvum in the United States.  44:1590-1591. 2006

Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: A multicenter prospective study.  44:1257-1261. 2006

Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India..  44:709-715. 2006

Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens.  44:366-373. 2006

Validation of a multiplex pneumococcal serotyping assay with clinical samples.  44:383-388. 2006

Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.  43:5295-5297. 2005

Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia.  43:4852-4854. 2005

Confirming positive results of Nucleic Acid Amplification Tests (NAATs) for Chlamydia trachomatis: A11 NAATs are not created equal.  43:1372-1373. 2005

Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.  43:577-584. 2005

Long-term molecular analysis of tuberculosis strains in Alabama, a state characterized by a largely indigenous, low-risk population.  43:870-878. 2005

Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.  43:127-131. 2005

Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.  43:156-162. 2005

Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections.  42:4749-4758. 2004

Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.  42:3363-3365. 2004

Performance of a new, rapid assay for detection of Trichomonas vaginalis.  42:2940-2943. 2004

Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea.  41:5787-5791. 2003

Epidemiology of Aspergillus terreus at a University Hospital.  41:5525-5529. 2003

Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis.  41:3784-3789. 2003

Bacillus cereus bacteremia in a preterm neonate.  41:3441-3444. 2003

Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.  41:2458-2464. 2003

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.  41:304-309. 2003

Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea.  40:3596-3601. 2002

Evaluation of the Digene Hybrid Capture II assay with the Rapid Capture System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  40:3558-3564. 2002

Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.  40:3757-3763. 2002

Improved detection by DNA amplification of Trichomonas vaginalis in males.  40:3681-3683. 2002

PCR-based identification of bacteria associated with endodontic infections.  40:3223-3231. 2002

Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies.  40:3064-3065. 2002

Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis Infection.  40:1555-1557. 2002

Comparison of Digene Hybrid Capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.  40:641-644. 2002

Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures.  39:4328-4331. 2001

Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.  39:3877-3882. 2001

Relative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men.  39:3927-3937. 2001

Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.  39:3709-3711. 2001

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results.  39:3092-3098. 2001

Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens.  39:3197-3199. 2001

Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.  39:1008-1016. 2001

Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.  39:1092-1096. 2001

Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobe.  39:570-573. 2001

The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters).  38:3133-3134. 2000

Microascus cinereus (anamorph Scopulariopsis) brain abscess in a bone marrow transplant recipient.  38:395-397. 2000

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.  38:2043-2050. 2000

Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.  38:3585-3588. 2000

Evaluation of nucleic acid amplification tests as reference tests for chlamydia trachomatis infections in asymptomatic men.  38:4382-4386. 2000

Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.  38:4548-4553. 2000

InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens.  38:3825-3826. 2000

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.  38:3544-3549. 2000

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis.  38:1105-1112. 2000

Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.  38:1731-1734. 2000

Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.  37:3668-3671. 1999

Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.  37:3583-3585. 1999

Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.  37:2369-2370. 1999

Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assay.  37:3072-3073. 1999

Detection of antibody to avian influenza a (H5N1) virus in human serum by using a combination of serologic assays.  37:937-943. 1999

Viability of Trichomonas vaginalis in transport medium.  37:3749-3750. 1999

Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.  36:2229-2234. 1998

Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens.  36:3234-3238. 1998

Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels.  36:2052-2056. 1998

Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates.  36:3686-3688. 1998

Evaluation of the biostar chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic.  36:2183-2186. 1998

Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.  36:3552-3557. 1998

Detection of Mycoplasma pulmonis in cilia-associated respiratory bacillus isolates and in respiratory tracts of rats by nested PCR.  35:1667-1670. 1997

Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.  35:354-357. 1997

Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs.  35:2129-2132. 1997

Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs.  35:2133-2135. 1997

Evaluation of the Vidas Chlamydia test to detect and verify Chlamydia trachomatis in urogenital specimens.  35:2102-2106. 1997

Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.  35:1618-1619. 1997

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group..  34:912-917. 1996

Diagnosis of cytomegalovirus infection in pediatric Menetrier's disease by in situ hybridization.  34:2588-2589. 1996

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States.  34:912-917. 1996

Prevalence of fluorescent monoclonal antibody-nonreactive Neisseria gonorrhoeae in five North American sexually transmitted disease clinics.  34:1551-1552. 1996

Comparison of four DNA-based methods for strain delineation of Candida lusitaniae.  33:1467-1470. 1995

Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans.  33:1890-1895. 1995

Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.  33:455-457. 1995

Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.  33:3111-3114. 1995

Rapid antigen detection assay for identification of Chlamydia trachomatis infection.  33:1920-1921. 1995

Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)..  32:3064-3067. 1994

Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men.  32:24-27. 1994

Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences.  32:2959-2961. 1994

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix.  32:2540-2543. 1994

Optimization of quantitative culture assay for human immunodeficiency virus from plasma.  32:3064-3067. 1994

Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea.  31:351-353. 1993

Cultivation of cilia-associated respiratory bacillus in artificial medium and determination of the 16S rRNA gene sequence.  31:2751-2757. 1993

Evaluation of intraspecies genetic variation within the 16S rRNA gene of Mycoplasma hominis and detection by polymerase chain reaction.  31:1358-1361. 1993

Application of directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens.  30:1072-1075. 1992

Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay.  30:1014-1015. 1992

Differentiation of Giardia duodenalis from other Giardia spp. by using polymerase chain reaction and gene probes.  30:74-78. 1992

Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection.  30:721-723. 1992

Identification of two new antigenic subgroups within the genus Mobiluncus.  29:2204-2208. 1991

Use of a urine enzyme immunoassay as a diagnostic tool for chlamydia trachomatis urethritis in men.  29:2446-2449. 1991

Demonstration of heterogeneity among the antigenic proteins of Mobiluncus species.  28:463-468. 1990

Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.  28:1541-1544. 1990

Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses.  28:1229-1235. 1990

Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women.  28:2473-2476. 1990

Comparison of GC-Lect and modified Thayer-Martin media for isolation of Neisseria gonorrhoeae.  27:808-811. 1989

Effect of differences in specimen processing and passage technique on recovery of Chlamydia trachomatis.  27:894-898. 1989

Elevated levels of immunoglobulin A to Giardia lamblia during a waterborne outbreak of gastroenteritis.  27:1707-1710. 1989

New fluorescence assay for the quantitation of fungi.  27:2003-2007. 1989

Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus.  27:2451-2454. 1989

Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.  26:1635-1640. 1988

Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults.  26:896-900. 1988

Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics.  25:868-872. 1987

Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures.  25:2388-2390. 1987

Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens.  24:1029-1033. 1986

Effect of medium and cultivation conditions on comparisons between latex agglutination and culture detection of group A streptococci.  24:644-646. 1986

Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.  23:725-730. 1986

Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody.  22:241-244. 1985

Detection of cytomegalovirus antibody with latex agglutination.  22:68-70. 1985

Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans.  22:259-264. 1985

Elevated serum D-arabinitol levels in patients with sarcoidosis.  19:26-29. 1984

Epidemiological studies of Streptococcus pneumoniae in infants: Development of antibody to phosphocholine.  18:1102-1107. 1983

Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas.  16:408-410. 1982

Carbohydrate fingerprints of streptococcal cells.  13:89-92. 1981

Improved diagnostic accuracy using monoclonal antibody to group A streptococcal carbohydrate.  12:506-508. 1980

Atypical isolate of Cryptococcus neoformans cultured from sputum of a patient with pulmonary cancer and blastomycosis.  7:316-318. 1978